- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Celyad Oncology (NASDAQ:CYAD), Quotes and News Summary
Celyad Oncology (NASDAQ: CYAD)
Earnings
see more| FY 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-12-20 | ||||||
| REV | |||||||
| FY 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-11-09 | ||||||
| REV | |||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Celyad Oncology Questions & Answers
You can purchase shares of Celyad Oncology (NASDAQ: CYAD) through any online brokerage.
Other companies in Celyad Oncology’s space includes: Acurx Pharmaceuticals (NASDAQ:ACXP), Synaptogenix (NASDAQ:SNPX), GlycoMimetics (NASDAQ:GLYC), Eledon Pharma (NASDAQ:ELDN) and OKYO Pharma (NASDAQ:OKYO).
The latest price target for Celyad Oncology (NASDAQ: CYAD) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 0.09 expecting CYAD to fall to within 12 months (a possible -95.63% downside). 50 analyst firms have reported ratings in the last year.
The stock price for Celyad Oncology (NASDAQ: CYAD) is $2.06 last updated August 11, 2022, 5:48 PM UTC.
The next Celyad Oncology (CYAD) dividend date is projected to be Monday, August 22, 2022.
Celyad Oncology’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Celyad Oncology.
Celyad Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.